Latest filing published 20 Mar 2026 for IOL Chemicals and Pharmaceuticals Limited, €282k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +82.0%Entry ₹71.56 · Close at T+90 ₹130.21
- +72.5%Entry ₹74.36 · Close at T+90 ₹128.30
- +38.1%Entry ₹72.65 · Close at T+90 ₹100.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
NCVI Enterprises Limited: trading record in brief
This profile gathers the share dealings of NCVI Enterprises Limited in IOL Chemicals and Pharmaceuticals Limited. The record holds 3 filings, for trades running from 16 March 2026 to 19 March 2026.
Every open-market trade on record is a purchase: 3 purchases worth €1.2M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €451k. As a share of market capitalisation, the median purchase stands at 0.11%, based on 3 purchases. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of +72.5%, with the price up in 100% of them. Past outcomes like these are no guarantee of what comes next.
Most recently, on 20 March 2026, the filings show an open-market purchase worth €282k in IOL Chemicals and Pharmaceuticals Limited. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to NCVI Enterprises Limited
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 404,305 shares@ ₹74.5580.066% mcap36.9% of flowEquity SharesSEBI:2d42ae11236b05cf57ec3bfaee04b80e49652f17Canonical exit: 17 Jun 2026 (T+90)
- 700,000 shares@ ₹73.44110.11% mcap63.1% of flowEquity SharesSEBI:853be90ccf3f42c7e6f9347b08247ca9cf2cdf94Canonical exit: 16 Jun 2026 (T+90)
- 700,000 shares@ ₹68.88710.11% mcap100.0% of flowEquity SharesSEBI:1f9f9591a0aa30341610bb92a8cc860bfe32b53fCanonical exit: 14 Jun 2026 (T+90)
3 of 3 declarations